Related references
Note: Only part of the references are listed.Elevated TGFI3 signaling contributes to ocular anterior segment dysgenesis in Col4a1 mutant mice
Mao Mao et al.
MATRIX BIOLOGY (2022)
Guidelines for the measurement of vascular function and structure in isolated arteries and veins
Camilla F. Wenceslau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)
PIP2 as the coin of the realm for neurovascular coupling
Scott Earley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity
Fabrice Dabertrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Species-Specific Effects of Cation Channel TRPM4 Small-Molecule Inhibitors
Prakash Arullampalam et al.
FRONTIERS IN PHARMACOLOGY (2021)
Nitric Oxide Signals Through IRAG to Inhibit TRPM4 Channels and Dilate Cerebral Arteries
Sher Ali et al.
FUNCTION (2021)
PIP2 Improves Cerebral Blood Flow in a Mouse Model of Alzheimer's Disease
Amreen Mughal et al.
FUNCTION (2021)
Reducing Hypermuscularization of the Transitional Segment Between Arterioles and Capillaries Protects Against Spontaneous Intracerebral Hemorrhage
Julien Ratelade et al.
CIRCULATION (2020)
COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity
Cassandre Labelle-Dumais et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
CNS small vessel disease A clinical review
Rocco J. Cannistraro et al.
NEUROLOGY (2019)
Identification of potent and selective small molecule inhibitors of the cation channel TRPM4
Lijo Cherian Ozhathil et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Severity of arterial defects in the retina correlates with the burden of intracerebral haemorrhage in COL4A1-related stroke
Julien Ratelade et al.
JOURNAL OF PATHOLOGY (2018)
Neurologic phenotypes associated with COL4A1/2 mutations Expanding the spectrum of disease
Sara Zagaglia et al.
NEUROLOGY (2018)
Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations
Marion Jeanne et al.
MATRIX BIOLOGY (2017)
TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α
Anahita Hamidi et al.
SCIENCE SIGNALING (2017)
GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway
Jing Xie et al.
ONCOTARGET (2017)
TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α
Anahita Hamidi et al.
SCIENCE SIGNALING (2017)
Vascular Cognitive Impairment
Martin Dichgans et al.
CIRCULATION RESEARCH (2017)
Molecular and Genetic Analyses of Collagen Type IV Mutant Mouse Models of Spontaneous Intracerebral Hemorrhage Identify Mechanisms for Stroke Prevention
Marion Jeanne et al.
CIRCULATION (2015)
The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature
Marije E. C. Meuwissen et al.
GENETICS IN MEDICINE (2015)
Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease
Fabrice Dabertrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations
Debbie S. Kuo et al.
HUMAN MOLECULAR GENETICS (2014)
A PLCγ1-Dependent, Force-Sensitive Signaling Network in the Myogenic Constriction of Cerebral Arteries
Albert L. Gonzales et al.
SCIENCE SIGNALING (2014)
Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer
Long Zhang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Endogenous cytosolic Ca2+ buffering is necessary for TRPM4 activity in cerebral artery smooth muscle cells
Albert L. Gonzales et al.
CELL CALCIUM (2012)
COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets
Debbie S. Kuo et al.
HUMAN MOLECULAR GENETICS (2012)
Ca2+ release from the sarcoplasmic reticulum is required for sustained TRPM4 activity in cerebral artery smooth muscle cells
Albert L. Gonzales et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscle
Albert L. Gonzales et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Collagen Structure and Stability
Matthew D. Shoulders et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease
Kenju Hara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mammalian collagen IV
Jamshid Khoshnoodi et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2008)
Extracellular control of TGFβ signalling in vascular development and disease
Peter ten Dijke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus:: An extension of the Col4α1 allelic series and the identification of the first two Col4a2 mutant Alleles
Jack Favor et al.
GENETICS (2007)
Role of COL4A1 in small-vessel disease and hemorrhagic stroke
DB Gould et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate
B Nilius et al.
EMBO JOURNAL (2006)
Phosphatidylinositol 4,5-bisphosphate rescues TRPM4 channels from desensitization
Z Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly
DB Gould et al.
SCIENCE (2005)
Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries
S Earley et al.
CIRCULATION RESEARCH (2004)
Voltage dependence of the Ca2+-activated cation channel TRPM4
B Nilius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization
P Launay et al.
CELL (2002)
Share Paper
